Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.21+0.20 (+9.95%)
Close on Nov 13, 2026Market cap $3.21MP/E –Yield –
Nexentis Technologies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Nexentis Technologies's ebitda for the twelve months ending Jun 30, 2026 was -$10.62M. For fiscal 2025 it was -$4.16M. The highest annual figure on record is -$443.07K in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.16M | – |
| FY2024 | Dec 31, 2024 | -$3.27M | – |
| FY2023 | Dec 31, 2023 | -$7.56M | – |
| FY2022 | Dec 31, 2022 | -$5.76M | – |
| FY2021 | Dec 31, 2021 | -$4.65M | – |
| FY2020 | Dec 31, 2020 | -$1.30M | – |
| FY2019 | Dec 31, 2019 | -$1.90M | – |
| FY2018 | Dec 31, 2018 | -$443.07K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.77M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.14M | – |
| Q4 FY2025 | Dec 31, 2025 | $612.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.32M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.63M | – |
| Q1 FY2025 | Mar 31, 2025 | -$500.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$216.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.43M | – |
| Q2 FY2024 | Jun 30, 2024 | -$842.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$894.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.15M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.84M | – |
| Q2 FY2023 | Jun 30, 2023 | -$829.52K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.73M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.41M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.76M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.27M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.34M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.53M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.29M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.62M | – |
| Q1 FY2021 | Mar 31, 2021 | -$242.06K | – |
| Q4 FY2020 | Dec 31, 2020 | -$148.93K | – |
| Q3 FY2020 | Sep 30, 2020 | -$415.56K | – |
| Q2 FY2020 | Jun 30, 2020 | -$396.88K | – |
| Q1 FY2020 | Mar 31, 2020 | -$342.78K | – |
| Q4 FY2019 | Dec 31, 2019 | -$537.42K | – |
| Q3 FY2019 | Sep 30, 2019 | -$495.86K | – |
| Q2 FY2019 | Jun 30, 2019 | -$528.59K | – |
| Q1 FY2019 | Mar 31, 2019 | -$342.09K | – |
See a number that looks wrong?